Markets
Leaderboard
RaniPill microneedle pill to replace injections: approved for sale by the end of 2026? Yes: real money 10%, play money 32% No: real money 90%, play money 68% Volume: real money 689.408199, play money 21400.23903874 Bettors: real money 9, play money 35 Categories: Science, Drug Development Related markets Will the FDA approve a psilocybin treatment during 2026? (ID: 239433) Volume: real 106.15796381, play 10000.1 Bettors: real 4, play 2 Leading (real money): Will the FDA approve a psilocybin treatment during 2026? 19% Leading (play money): Will the FDA approve a psilocybin treatment during 2026? 20%

RaniPill microneedle pill to replace injections: approved for sale by the end of 2026?

Market Rules

Scientists at Rani Therapeutics in California (USA) developed a pill called RaniPill to replace painful injections of drugs that cannot be taken orally. This is interesting because painful treatments reduce patient compliance, which can be harmful to health.

The pill passes through the stomach and arrives intact in the intestine, where it dissolves. A small balloon is then inflated and punctures a tiny needle in the intestine, injecting the substance that is carried by the pill. The balloon with the needle then deflates and is then evacuated.

Human tests for the pill were performed in Australia in 2019, where patients did not report any discomfort, and the pill's effectiveness was the same as a conventional injection. The company responsible for the pill continues to run tests and trials, aimed at receiving the FDA approval for commercializing the pill as a substitute for injections.

If RaniPill is approved for sale by December 31, 2026, this market will resolve to "Yes".

Related Markets